Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Supar Health ApS
APS
Active
Advertising protection
CVR 41298790
Strandvejen 64D, 2900
Hellerup
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2020 · 6 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of basic pharmaceutical products
/
Supar Health ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
—
—
0
0
-333
Staff expenses
-0
-0
-0
-0
-0
EBITDA
0
0
0
0
-333
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
0
0
0
0
-333
Net financials
0
0
0
0
0
Profit before tax
0
0
0
0
-332
Tax
-0
-0
-0
-0
-0
Net profit
0
0
0
0
-332
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
40
40
35
35
115
Equity
40
40
1
35
-298
Long-term debt
0
0
0
0
0
Short-term debt
0
0
34
0
412
Total debt
0
0
34
0
412
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-33264800.0%
This company
2021
2025
Equity ratio
-259.6%
This company
38.2%
Market median
-780% vs market
2021
2025
Return on equity
-33247400.0%
This company
18.4%
Market median
-180692491% vs market
2021
2025
Net profit margin (of gross profit)
-33247400.0%
This company
2021
2025
Asset turnover (of gross profit)
-2.90×
This company
2021
2025
Debt / equity
1.39×
This company
0.62×
Market median
-124% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-04-16 – 2021-09-30
View
PDF
More on Supar Health ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
